Allergan Wants ITC To Eye Rival Version Of Botox
Allergan wants the U.S. International Trade Commission to probe whether a California-based medical aesthetics company and a South Korean-based pharmaceutical company are violating the Tariff Act with a version of Botox...To view the full article, register now.
Already a subscriber? Click here to view full article